The future of pharmaceutical naming starts now
For decades, pharmaceutical naming has relied on traditional methods that compromise creativity and strategy just to meet complex regulatory and trademark requirements. But it's time for a transformation.
Meet Predictive Naming, amplified by Ari™.
Ari is the first and only AI-driven pharmaceutical naming platform, designed to revolutionize how brands are created. By combining 35 years of human expertise with cutting-edge AI, Ari doesn't replace creativity - it amplifies it, unlocking smarter, faster and more strategic name development while ensuring compliance with global regulatory and trademark standards.
No more compromises. No more roadblocks. Just trademarks without tradeoffs.
Why Ari™?
- AI-powered & human-driven: Enhances creativity, expands exploration, and delivers strategically inspired brand names.
- Built for pharma: Designed specifically to navigate the complexities of regulatory and trademark challenges.
- Seamless screening: Integrated POCA, real-time trademark assessments, and regulatory compliance checks for FDA, EMA, and more.
- Confidential & secure: A proprietary, closed-platform solution that protects sensitive information.
- One unified solution: A single source of truth that streamlines collaboration across disciplines, making the process more efficient and future-proof.
The future of pharma naming is here. Are you ready to experience it?
Sign up for a demo today to see Ari™ in action.
Get More Information
Complete this form to request a demo and receive an exclusive white paper download.